Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Net Margin (2020 - 2024)

Agilon Health's Net Margin history spans 5 years, with the latest figure at 0.08% for Q3 2024.

  • For Q3 2024, Net Margin rose 75.0% year-over-year to 0.08%; the TTM value through Jun 2025 reached 0.02%, up 137.0%, while the annual FY2025 figure was 0.24%, 38.0% up from the prior year.
  • Net Margin reached 0.08% in Q3 2024 per AGL's latest filing, down from 0.03% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 3.8% in Q4 2020 to a low of 14.02% in Q4 2021.
  • Average Net Margin over 5 years is 1.18%, with a median of 0.08% recorded in 2023.
  • Peak YoY movement for Net Margin: tumbled -1782bps in 2021, then soared 1388bps in 2022.
  • A 5-year view of Net Margin shows it stood at 3.8% in 2020, then tumbled by -469bps to 14.02% in 2021, then surged by 99bps to 0.14% in 2022, then tumbled by -4117bps to 6.0% in 2023, then soared by 99bps to 0.08% in 2024.
  • Per Business Quant, the three most recent readings for AGL's Net Margin are 0.08% (Q3 2024), 0.03% (Q1 2024), and 6.0% (Q4 2023).